SELLAS Life Sciences (SLS) Current Leases (2010 - 2026)
SELLAS Life Sciences' (SLS) quarterly Current Leases came in at $562000.0 in Q1 2026, little changed year-on-year from $561000.0 in Q1 2025, and up 3.31% on a QoQ basis from $544000.0 in Q4 2025.
SELLAS Life Sciences (SLS) Current Leases (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 13 years of Current Leases data on file, last reported at $562000.0 in Q1 2026.
- On a quarterly basis, Current Leases changed 0.18% year-over-year to $562000.0 in Q1 2026; TTM through Mar 2026 was $562000.0, a 0.18% change from a year earlier, with the FY2025 full-year figure at $544000.0, changed 0.0% from the prior year.
- Current Leases for Q1 2026 stood at $562000.0, up from $544000.0 in the prior quarter.
- Over the last five years, Current Leases for SLS reached as high as $599000.0 in Q3 2025 and fell as low as $325000.0 in Q1 2022.
- Historically, Current Leases has averaged $480294.1 across 5 years, with a median of $488000.0 in 2024.
- Across the five-year window, Current Leases jumped 87.88% in 2022 and changed 0.0% in 2025, its largest moves.
- Year by year, Current Leases stood at $372000.0 in 2022, then increased by 19.89% to $446000.0 in 2023, then climbed by 21.97% to $544000.0 in 2024, then changed by 0.0% to $544000.0 in 2025, then gained by 3.31% to $562000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $562000.0 in Q1 2026, $544000.0 in Q4 2025, and $599000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | 544,000.00 |
| Sep 30, 2025 | 599,000.00 |
| Jun 30, 2025 | 580,000.00 |
| Mar 31, 2025 | 561,000.00 |
| Dec 31, 2024 | 544,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 531,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 466,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | 427,000.00 |
| Dec 31, 2022 | 372,000.00 |
| Sep 30, 2022 | 356,000.00 |
| Jun 30, 2022 | 341,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 198,000.00 |
| Sep 30, 2021 | 190,000.00 |
| Jun 30, 2021 | 182,000.00 |